Christoph Huber

Christoph Huber is a founding figure in cancer immunotherapy who co-founded several biotechnology companies translating novel antibody and vaccine approaches from academic research to clinical development. His work at the University Medical Center Mainz on understanding T cell recognition of tumor antigens has informed the design of T cell-engaging bispecific antibodies. He has been a key advocate for the translation of innovative bifunctional antibody formats from academic laboratories to clinical testing.